PI
PFG Investments Portfolio holdings
AUM
$1.71B
1-Year Return
22.04%
This Quarter Return
+11.43%
1 Year Return
+22.04%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.71B
AUM Growth
+$147M
(+9.4%)
Cap. Flow
+$27M
Cap. Flow
% of AUM
1.58%
Top 10 Holdings %
Top 10 Hldgs %
25.16%
Holding
1,135
New
118
Increased
486
Reduced
383
Closed
89
Top Buys
| 1 |
AXS Change Finance ESG ETF
CHGX
|
$10.5M |
| 2 |
PIMCO Enhanced Short Maturity Active ESG ETF
EMNT
|
$7.92M |
| 3 |
Invesco NASDAQ 100 ETF
QQQM
|
$3.84M |
| 4 |
Invesco S&P 500 Quality ETF
SPHQ
|
$3.58M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
$2M |
Top Sells
| 1 |
CHGX
AXS Change Finance ESG ETF
CHGX
|
$9.76M |
| 2 |
InterGroup Corp
INTG
|
$4.18M |
| 3 |
Invesco QQQ Trust
QQQ
|
$4.01M |
| 4 |
iShares Russell Top 200 Growth ETF
IWY
|
$2.73M |
| 5 |
Prospect Capital
PSEC
|
$1.94M |
Sector Composition
| 1 | Technology | 21.77% |
| 2 | Consumer Discretionary | 7.28% |
| 3 | Financials | 7.02% |
| 4 | Communication Services | 5.94% |
| 5 | Healthcare | 4.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
iHeartMedia
IHRT
$315M
| $59K | ﹤0.01% |
33,500
+2,500
| +8% | +$4.4K |
|
|
OXLC
1002
Oxford Lane Capital
OXLC
$1.75B
| $58.1K | ﹤0.01% |
13,827
-2,722
| -16% | -$11.4K |
|
1003
B&G Foods
BGS
$374M
| $48.3K | ﹤0.01% |
11,422
-4,832
| -30% | -$20.4K |
|
|
DHY
1004
Credit Suisse High Yield Bond Fund
DHY
$217M
| $48.2K | ﹤0.01% |
22,630
| – | – |
|
1005
Altimmune
ALT
$334M
| $46.4K | ﹤0.01% |
12,000
-5,500
| -31% | -$21.3K |
|
|
MOB
1006
Mobilicom
MOB
$50.4M
| $45.4K | ﹤0.01% |
18,000
| – | – |
|
|
LAC
1007
Lithium Americas
LAC
$698M
| $45.1K | ﹤0.01% |
16,814
-17,802
| -51% | -$47.7K |
|
1008
Rocket Pharmaceuticals
RCKT
$354M
| $44.3K | ﹤0.01% |
18,100
+4,700
| +35% | +$11.5K |
|
|
GGT
1009
Gabelli Multimedia Trust
GGT
$142M
| $44.1K | ﹤0.01% |
10,686
+3
| +0% | +$12 |
|
|
1010
Prospect Capital
PSEC
$1.34B
| $44.1K | ﹤0.01% |
13,864
-610,555
| -98% | -$1.94M |
|
1011
Arbutus Biopharma
ABUS
$805M
| $43.9K | ﹤0.01% |
14,200
| – | – |
|
1012
Tilray
TLRY
$1.31B
| $43.8K | ﹤0.01% |
105,778
-24,945
| -19% | -$10.3K |
|
1013
Trinseo
TSE
$88.1M
| $43.7K | ﹤0.01% |
14,002
+2
| +0% | +$6 |
|
1014
AbCellera Biologics
ABCL
$1.26B
| $42.9K | ﹤0.01% |
12,500
| – | – |
|
1015
Gold Royalty Corp
GROY
$656M
| $42.8K | ﹤0.01% |
+19,353
| New | +$42.8K |
|
1016
FerroAtlántica
GSM
$799M
| $41.7K | ﹤0.01% |
11,370
| – | – |
|
1017
Cardiff Oncology
CRDF
$144M
| $39.4K | ﹤0.01% |
12,501
| – | – |
|
1018
Solid Power
SLDP
$760M
| $36.1K | ﹤0.01% |
16,500
| – | – |
|
|
MIN
1019
MFS Intermediate Income Trust
MIN
$307M
| $34.6K | ﹤0.01% |
12,777
| – | – |
|
1020
Beam Global
BEEM
$44.7M
| $28.6K | ﹤0.01% |
19,578
-300
| -2% | -$438 |
|
1021
Lucid Motors
LCID
$5.66B
| $27.5K | ﹤0.01% |
1,301
+115
| +10% | +$2.43K |
|
1022
INmune Bio
INMB
$51.8M
| $26.6K | ﹤0.01% |
+11,500
| New | +$26.6K |
|
|
BZUN
1023
Baozun
BZUN
$207M
| $25.5K | ﹤0.01% |
10,200
| – | – |
|
|
CGC
1024
Canopy Growth
CGC
$456M
| $19.7K | ﹤0.01% |
16,147
+4,000
| +33% | +$4.88K |
|
1025
Lineage Cell Therapeutics
LCTX
$279M
| $19.2K | ﹤0.01% |
21,202
| – | – |
|